- Published
- 24 April 2020
- Journal article
Handling of allergen immunotherapy in the COVID-19 pandemic:An ARIA-EAACI statement
- Authors
-
- Source
- Allergy
Full text
Abstract
The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient.
Rights
http://onlinelibrary.wiley.com/termsAndConditions#vor http://doi.wiley.com/10.1002/tdm_license_1.1
Cite as
Klimek, L., Jutel, M., Akdis, C., Bousquet, J., Akdis, M., Bachert, C., Agache, I., Ansotegui, I., Bedbrook, A., Bosnic-Anticevich, S., Canonica, G., Chivato, T., Cruz, A., Czarlewski, W., Del Giacco, S., Du, H., Fonseca, J., Gao, Y., Haahtela, T., Hoffmann‐Sommergruber, K., Ivancevich, J., Khaltaev, N., Knol, E., Kuna, P., Larenas-Linnemann, D., Melén, E., Mullol, J., Naclerio, R., Ohta, K., Okamoto, Y., O'Mahony, L., Onorato, G., Papadopoulos, N., Pawankar, R., Pfaar, O., Samolinski, B., Schwarze, J., Toppila-Salmi, S., Shamji, M., Ventura, M., Yorgancioglu, A., Matricardi, P. & Zuberbier, T. 2020, 'Handling of allergen immunotherapy in the COVID-19 pandemic:An ARIA-EAACI statement', Allergy, 75(7), pp. 1546-1554. https://doi.org/10.1111/all.14336